Probi extends the collaboration with Health World Australia by the launch of Probi Defendum®
Probi has signed an extension to the long term distribution agreement with Health World Limited, Australia and New Zealand´s market leading probiotic provider. Health World, being Probi´s first partner in the Consumer Healthcare business has successfully been selling Probi Digestis®for 8 years and Health World will now extend their product offering by adding Probi´s immune product Probi Defendum® to their range.The launch is scheduled for Q1 2014.
“We are very happy to broaden the successful long-term collaboration with Health World to also include the Probi Defendum® product. Health World, being the leading player in the Australian probiotic market, is the ideal partner for us” says Gun-Britt Fransson, interim CEO of Probi.
“After years of successful sales and marketing of Probi Digestis® we are happy to add a new probiotic concept from Probi, Probi Defendum®. In line with Probi´s proven R&D strategy the product has good and solid clinical documentation. We are looking forward to continue the close collaboration with Probi and take part in Probi´s growing probiotic pipeline” Says Graeme Joiner, Director of Sales & Marketing, Health World.
Probi Defendum® is based on the combination of two probiotic strains, Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2. It has been proven in large clinical studies to prevent common colds, significantly reduce cold symptoms and shorten cold periods.
The information is such that Probi AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.
FOR FURTHER INFORMATION, CONTACT:
Gun-Britt Fransson, interim CEO, Probi, phone. +46 46 286 89 74 or mobile +46 705 95 73 27, e-mail: Gun-Britt.Fransson@probi.se
Niklas Bjärum, Vice President Marketing & Sales, Probi, phone. +46 46 286 89 67 or, mobile: +46 705 38 88 64, e-mail: niklas.bjarum@probi.se
ABOUT PROBI
Probi is a leading player in the probiotic research and the development of efficient and well-documented probiotics. The research areas include: gastrointestinal tracts, immune system, metabolic syndrome and stress and recovery. Probi’s customers are leading companies in the Functional Foods and Consumer Healthcare segments. Total income for 2012 was MSEK 100.4. Probi’s share is listed on the Nasdaq OMX Stockholm, Small Cap. Probi has approximately 5,000 shareholders. Read more on www.probi.com.
ABOUT HEALTH WORLD
Health World is a leading supplier of natural medicines in Australia and New Zealand by providing high quality, effective products based on the latest scientific research. Health World ensures product quality, safety and efficacy by strictly analysing and testing their products on site at their purpose built manufacturing facility in Northgate, Queensland.
Tags: